Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01107314 · ClinicalTrials.gov registry record
Vasopressin Deficiency in Hemorrhagic Shock
A clinical trial of Body Response to Trauma, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- 81
- Enrollment target
- 1
- Study location
NCT01107314 is a study of Body Response to Trauma that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 81 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01107314, a study of Body Response to Trauma, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- 81 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study we hope to delineate the typical vasoactive mediator response of trauma patients to shock. We plan to assess serum levels of vasopressin and also catecholamines, angiotensin, and cortisol during resuscitation of trauma patients to delineate high risk populations for vasopressin deficiency.
Conditions Studied
Interventions
- OTHER Phlebotomy
Study Locations (1)
Texas
- UTHSCSA - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2010-02 |
| Est. Completion | 2011-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01107314
The ClinicalTrials.gov registry entry for NCT01107314 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Body Response to Trauma appearing as the primary indexed condition, and to 1 intervention - of which Phlebotomy is the first listed.
NCT01107314 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01107314 about?
NCT01107314 is a clinical study titled "Vasopressin Deficiency in Hemorrhagic Shock". In this study we hope to delineate the typical vasoactive mediator response of trauma patients to shock. We plan to assess serum levels of vasopressin and also catecholamines, angiotensin, and cortisol during resuscitation of trauma patients to delineate high risk populations for vasopressin deficie...
What is the current status of trial NCT01107314?
This trial is currently completed. The enrollment target is 81 participants. The study started on 2010-02. Estimated completion is 2011-04-30.
What conditions does trial NCT01107314 study?
This clinical trial studies the following conditions: Body Response to Trauma.
What interventions are being tested in trial NCT01107314?
The interventions under investigation include: Phlebotomy (OTHER).
Who is sponsoring clinical trial NCT01107314?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01107314 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.